Skip to content

Clinical trials

Phase 3 Albuminuria trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Albuminuria Phase: Phase 3 Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20071
20121
20132
20151
20163
20171
20221
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Terminated2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Keryx Biopharmaceuticals2
University Medical Center Groningen2
Daiichi Sankyo Co., Ltd.1
Institut de Recherches Cliniques de Montreal1
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran1
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's1
Oslo University Hospital1
Tulane University School of Public Health and Tropical Medicine1
University Medical Centre Ljubljana1
University of Chile1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Albuminuria13
Diabetic Nephropathies4
Renal Insufficiency, Chronic4
Diabetes Mellitus3
Hypertension3
Proteinuria3
Diabetes Mellitus, Type 22
Kidney Diseases2
Inflammation1
Obesity1

Trials

Showing 76 to 13 of 13. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.